Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Praharshinie Rupasinghe *Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-9858-8935
Nabila Ismail *South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-2287-1857
Wim MuldersUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-9566-3653
Robin M WarrenSouth African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0001-5741-7358
Lavania JosephCentre for Tuberculosis, National Institute for Communicable Diseases, a division of the National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0003-0734-7149
Dumisani NgcamuCentre for Tuberculosis, National Institute for Communicable Diseases, a division of the National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0002-9402-8615
Thabisile GwalaCentre for Tuberculosis, National Institute for Communicable Diseases, a division of the National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0002-7668-1178
Shaheed V OmarCentre for Tuberculosis, National Institute for Communicable Diseases, a division of the National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0001-6983-1636
Jens VereeckenUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0009-0001-9181-7053
Bouke C de JongUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-1017-4675
Leen RigoutsUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-3301-9480
Emanuele BorroniEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-6780-5119
Daniela M CirilloEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-6415-1535
Thomas SchönDepartment of Biomedical and Clinical Sciences, Division of Infection and Inflammation, Linkoping University, Linköping, Sweden.
Paolo MiottoEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-4610-2427
Claudio U KöserEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-0232-846X
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.